Fisher Asset Management’s Cogent Biosciences COGT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $796K | Hold |
110,908
| – | – | ﹤0.01% | 721 |
|
2025
Q1 | $664K | Hold |
110,908
| – | – | ﹤0.01% | 747 |
|
2024
Q4 | $865K | Sell |
110,908
-18,507
| -14% | -$144K | ﹤0.01% | 678 |
|
2024
Q3 | $1.4M | Sell |
129,415
-19,630
| -13% | -$212K | ﹤0.01% | 624 |
|
2024
Q2 | $1.26M | Buy |
149,045
+47,514
| +47% | +$401K | ﹤0.01% | 647 |
|
2024
Q1 | $682K | Sell |
101,531
-260
| -0.3% | -$1.75K | ﹤0.01% | 734 |
|
2023
Q4 | $599K | Buy |
101,791
+33,222
| +48% | +$195K | ﹤0.01% | 751 |
|
2023
Q3 | $669K | Hold |
68,569
| – | – | ﹤0.01% | 808 |
|
2023
Q2 | $812K | Hold |
68,569
| – | – | ﹤0.01% | 815 |
|
2023
Q1 | $740K | Hold |
68,569
| – | – | ﹤0.01% | 804 |
|
2022
Q4 | $793K | Hold |
68,569
| – | – | ﹤0.01% | 798 |
|
2022
Q3 | $1.02M | Buy |
+68,569
| New | +$1.02M | ﹤0.01% | 662 |
|